Pharmaceuticals
Eli Lilly to acquire Loxo Oncology for $8 bn in cash
09 Jan 2019
Loxo’s oncology drug Vitrakvi, priced at $32,800 per month, and experimental follow-up drug LOXO-195, on which Bayer is also a partner, together could generate annual sales of about $750 million
Bristol-Myers to acquire Celgene in $74-bn cash-and-stock deal
03 Jan 2019
Celgene shareholders will receive one Bristol-Myers Squibb share and $50 in cash for each share held, or $102.43 per share, a premium of 53.7 per cent to Celgene’s Wednesday close, besides one tradable contingent value right for each share held
J&J told to stop using its baby powder raw material in India
21 Dec 2018
Reports quoting an unnamed senior CDSCO official said on Thursday that Johnson & Johnson has been served with a written order to stop using the "huge quantities" of raw materials stocked in its plants in India
Aurobindo to buy Sandoz’s dermatology business in US for $1 bn
07 Sep 2018
Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline
